Olive leaf extract for heart artery health after heart attack
Part of Heart & circulation clinical trials.
This trial tests whether olive leaf extracts can improve the health of your blood vessels after a heart attack. If you had a specific type of heart attack with ST changes on your ECG and did not need immediate surgery or a second procedure, you may be eligible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old.
- You had a heart attack that showed ST-segment changes on your ECG, with or without a rise in troponin.
- You did not have bypass surgery and are not scheduled for another angioplasty (stent procedure) within 8 weeks of your first one.
- You are willing to come for follow-up visits and have a life expectancy of at least 2 years.
- You do not have severe thickening of the heart muscle, active cancer, inflammatory disease, serious valve disease, a pacemaker, cardiogenic shock, or active Crohn's disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether an olive extract supplement (Olivomed) improves how your blood vessels, heart, and circulation work. It focuses on people with stable or recently treated coronary heart disease and certain cholesterol patterns.
This trial tests a substance found in olive oil to see if it can protect against early signs of heart disease. You eat a special olive oil and have blood tests to see how your body responds.
This trial tests whether natural extracts and probiotics can improve gut health in people who have had a recent heart attack (Acute Coronary Syndrome). It uses special exams to measure changes in gut bacteria.
This trial studies whether olive leaf extract can help control diabetes. If you’re an adult with diabetes, you may be eligible to join and see how this supplement affects your blood sugar.
This trial tests two different blood-thinner strategies for people who have had a recent heart attack and also have a widened artery (ectasia) in the heart. The goal is to find the safest and most effective way to prevent another heart attack or clot.
This trial tests whether a powerful cholesterol-lowering drug (PCSK9 inhibitor) helps stabilize plaque in heart arteries after a recent heart attack or unstable angina treated with a stent. It may lower the risk of future heart problems.
Hear when a new Endothelial Dysfunction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.